The US medical aesthetic devices market size was exhibited at USD 16.71 billion in 2022 and is projected to hit around USD 42.38 billion by 2032, growing at a CAGR of 9.75% during the forecast period 2023 to 2032.
Medical Aesthetic Devices are used to overcome flaws in a person's physical appearance. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) estimates that in the United States in 2021, 1.4 million surgical and non-surgical operations were carried out. The top 5 cosmetic surgical procedure in the United States includes Facelift surgeries, Liposuction, Breast Augmentation, Nose reshaping, and eyelid surgery. The demand for aesthetic treatment in developing countries is growing due to the urge to look young and fit.
The aesthetic method such as liposuction, nose reshaping, and Botox injection are gaining consumer attention. Skin-tightening and non-invasive fat technologies have recently established out a new niche in the medical aesthetics market. The key factors enhancing the growth of the U.S. Aesthetic Medical Device market are a surge in the prevalence of facial deformities and congenital teeth, enhancement in demand for non-invasive surgeries, an increase in the number of cosmetic surgeries, and advancement in aesthetic devices.
COVID -19 Impact:
Manufacturers of cosmetic and aesthetic devices were ordered to cease manufacturing and supply because of the global lockdown that was implemented at the start of the COVID-19 pandemic. The pandemic had a significant impact on both invasive and non-invasive aesthetic operations, including the market for body contouring. For instance, according to Bloomberg, non-invasive fat removal, injectable lipolysis, invasive liposuction soft tissue fillers, facelifts, eye lifts, eyelid operations, laser skin resurfacing, rhinoplasty, and tummy tucks, saw a 20% decline in first half of 2020. However, according to The International Society of Aesthetic Plastic Surgery, by the end of 2020, the desire and demand for aesthetic procedures like body contouring had dramatically grown and had surpassed pre-pandemic levels.
Report Scope of the US Medical Aesthetic Devices Market
|Market Size in 2022||USD 16.71 Billion|
|Market Size by 2032||USD 42.38 Billion|
|Growth Rate from 2023 to 2032||CAGR of 9.75%|
|Forecast Period||2023 to 2032|
|Segments Covered||By Type of Device, By Application, By End User|
The rising prevalence of obesity, increased awareness of cosmetic treatments, expanding use of minimally invasive devices, and technical developments in devices are some factors that are fueling the market's growth.
The rise in the choice of minimally invasive and non-invasive cosmetic surgeries
High Awareness of cosmetic operations and rising obesity rates
High cost and side effects of the aesthetic surgery device
Accessibility to technologically advanced and user-friendly products
The breast implants sub-segment is Expected to show rapid grow in the implants segment of the market
Type of Device Insights
Based on the type of device, the U.S. Aesthetic Medical Device Market is segmented into Energy-based Aesthetic Devices and Non-energy-based Aesthetic Devices. The Energy-based Aesthetic Device is further segmented into Laser-based Aesthetic Devices, Radiofrequency (RF)-based Aesthetic Devices, Light-based Aesthetic Devices, and Ultrasound Aesthetic devices.
The Non-energy-based aesthetic device is segmented into botulinum toxin, dermal fillers and aesthetic threads, microdermabrasion, and others. In 2022 the implants (non-energy based) sector accounted for 79.40% of the aesthetic medicine market, because of rising demand for procedures like breast augmentation and face surgeries like rhinoplasty and blepharoplasty. In June 2020, JUVÉDERM® VOLUMATM XC of Allergan Aesthetics, a subsidiary of AbbVie Inc. (U.S.), was granted approval by the FDA for the augmentation of the chin area in people over the age of 21.
Based on application, the largest market share in 2022 is held by the skin resurfacing and tightening segment. This is due to the large population undergoing cosmetic treatment which includes skin resurfacing, and diminishing fine lines, wrinkles, and dark spots. The face aesthetics segment's revenue in 2020 was primarily driven by the growing demand for non-invasive cosmetic treatments and facial aesthetic operations. During the projected period, the market's feminine rejuvenation category is anticipated to grow at the largest CAGR. The most effective procedure for fat removal is liposuction. It removes up to 5 liters of fat from the procedure.
For instance, according to the American Society of Plastic Surgeons (ASPS), liposuction ranked second among procedures performed in the U.S. following breast augmentation, with 211,067 procedural volumes in 2020. During the projection period, non-surgical skin tightening is anticipated to see considerable market growth of 15.0%. This is due to the body's synthesis of collagen increasing with age but elastin decreasing, which causes fine lines and dull, sagging skin to appear.
Based on the end-user, the largest share of the medical aesthetic market is estimated to be accounted for by the hospitals and clinics segment, in 2022. The increased demand for minimally invasive cosmetic operations and the emergence of medical spas and clinics with infrastructure fully equipped with technologically advanced instruments/devices and skilled professionals are the two main drivers of this segment's growth.
Key Market Players
Segments Covered in the Report
By Type of Device
By End User
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client